Endocrine Abstracts

Introduction: Atherosclerosis is a chronic inflammatory arterial disease and is currently one of the most common causes of cardiovascular morbidity and mortality worldwide. Therefore, there is an urgent need to discover new therapeutic targets for treatment of this fatal chronic disease. Fatty acid binding protein 4 (FABP4), a pro-inflammatory adipokine that links obesity with its related metabolic diseases, has been implicated in the development of atherosclerosis. This study...